(Image created by StudyFinds with AI (OpenAI, 2025))
In A Nutshell
- A 6-week randomized crossover trial found no meaningful differences in heart-health markers between palmitic-rich and stearic-rich interesterified fats.
- Participants ate muffins and spreads providing 10% of daily calories from the test fats, an upper but realistic intake for heavy users.
- Cholesterol ratio, blood pressure, inflammation, vessel function, insulin measures, and liver fat were similar; IL-10 was slightly lower after the palmitic-rich fat.
- Results apply to healthy adults over six weeks; longer studies are needed to understand long-term effects and other populations.
LONDON — Food manufacturers can breathe a little easier after new research found that two widely used processed fats produced equivalent short-term effects on key blood markers of cardiovascular risk in healthy adults. A six-week study tested what happens when people eat high amounts of these fats, and the team reported equivalent short-term effects.
Forty-seven healthy adults consumed either palm-based fats or alternative processed fats as about 10% of their daily calories, far more than typical consumption but within the range of heavy users. Despite eating these elevated amounts for six weeks, people showed no meaningful differences in cholesterol levels, blood pressure, inflammation, or blood vessel function between the two fat types.
Palm-Rich and Stearic-Rich Blends: What Goes Into Your Spreads and Cookies
Food companies have relied heavily on these processed fats since trans fats were largely banned. The industry needed alternatives that could deliver the right texture, mouthfeel, and shelf life that consumers expect from baked goods, margarine, and countless packaged foods.
Two commercially used types are common in spreads and bakery applications: palm-based fats rich in palmitic acid and fully hydrogenated seed oil blends rich in stearic acid. Both undergo a process called interesterification that rearranges fat molecules to achieve desired properties without creating harmful trans fats.
Dr. Wendy Hall from King’s College London led the research team that decided to test these fats head-to-head. The researchers wrote that they aimed to compare the fat blends at realistic intake levels. Previous studies often used fats or doses that didn’t reflect what people actually encounter in the food supply.
How Researchers Fed Realistic High Intakes of Margarine-Style Fats
Participants consumed muffins and spreads that delivered 10% of daily calories from the assigned fat (approximately 19 grams per day for a 1700-kcal diet). This increased their intake of specific fatty acids by roughly 3-5% of total calories, akin to transitioning from moderate to heavy consumption of processed foods.
The research team tracked everything from basic cholesterol ratios to how blood vessels responded after high-fat meals. They measured inflammation markers, insulin sensitivity, blood pressure, and fat accumulation in the liver (measured at one center in a subgroup). Some participants underwent additional testing including flow-mediated dilation to assess blood vessel function and post-meal responses to fatty test meals.
The goal was straightforward: to determine whether one type of commercially used fat causes more cardiovascular problems than the other when consumed at levels that heavy users might actually reach.
Results at a Glance: No Meaningful Differences in Heart-Health Markers
After six weeks, both fat types produced nearly identical responses across virtually every measure. The study found no significant differences in:
- Total cholesterol to HDL cholesterol ratios, the primary outcome
- Blood pressure readings
- Inflammatory marker levels
- Blood vessel function
- Insulin sensitivity and glucose handling
- Liver fat accumulation
Post-meal responses, including triglycerides and other markers that spike after eating fatty foods, also showed no differences between the fat types. The only minor difference was a slight decrease in one anti-inflammatory protein among people eating palm-based fats, but researchers say this single finding needs more investigation.
What This Means for Food Manufacturing
These results, published in the American Journal of Clinical Nutrition, suggest that the choice between these two major fat types may be driven more by cost, availability, and processing considerations than health concerns. For an industry that has faced scrutiny over processed ingredients, the findings provide reassurance that current formulations aren’t creating the cardiovascular problems some critics feared.
However, the study comes with important caveats. It only examined healthy adults aged 35-65 for six weeks. The researchers acknowledge they don’t know what happens over months or years, or how people with existing health conditions might respond to long-term consumption.
Environmental and sourcing considerations remain separate issues. Palm oil production raises deforestation concerns, while alternative fat processing requires different agricultural inputs and energy. This study focused solely on health markers, leaving sustainability and sourcing decisions to other factors.
How the Findings Inform Safety Reviews and Label Decisions
The research addresses questions that have dogged the food industry since the trans fat phase-out. Companies needed alternatives that wouldn’t compromise product quality while meeting consumer health expectations. The study suggests that both major categories of replacement fats perform similarly from a cardiovascular standpoint over the timeframe tested.
Food manufacturers may find these results useful for product development and marketing decisions. Rather than reformulating based on fat type alone, companies might focus on other aspects of product nutrition and consumer acceptance.
The findings also provide context for regulators evaluating the safety of processed fats. While longer-term studies would strengthen the evidence base, the current research offers the most direct comparison yet of commercially relevant fat types at realistic consumption levels.
What Shoppers Should Know: Fat Type May Matter Less Than Overall Diet
For food companies, the research suggests that worrying about which specific processed fat to use might be less critical than previously thought, at least for short-term cardiovascular markers. This could simplify sourcing decisions and product development while addressing consumer health concerns.
The study doesn’t suggest that processed foods are risk-free or that people should eat more of them. Instead, it indicates that the two most common replacement fats for trans fats appear to affect the body similarly over six weeks when consumed at high but realistic levels.
Industry groups and consumer advocates will likely interpret these findings differently. Food manufacturers may point to the results as validation of current practices, while nutrition experts will probably emphasize the study’s limitations and the continued importance of overall diet quality.
The research provides valuable data for both sides of ongoing debates about processed food safety, though longer studies would help settle questions about durability and long-term effects.
Disclaimer: This article is for general information and education only. It is not medical or nutrition advice. Talk with your healthcare professional about choices that fit your health.
Paper Summary
Methodology
Researchers conducted a randomized, double-blind crossover trial at King’s College London and Maastricht University. Forty-seven healthy adults aged 35 to 65 consumed either palmitic acid-rich or stearic acid-rich interesterified fats for six weeks each, with a four-week break between interventions. The fats were delivered through specially formulated muffins and spreads, providing 10% of participants’ daily energy intake. Researchers measured fasting blood markers and responses after high-fat meals before and after each intervention period. The primary outcome was the total:HDL cholesterol ratio, tested for equivalence within a prespecified margin of ±0.09.
Results
No significant differences emerged between fat types for the main outcome or most other measures, including blood pressure, inflammatory markers, blood vessel function, and insulin sensitivity. Responses after fatty meals also showed no differences between the fat types. The only notable difference was a decrease in the anti-inflammatory cytokine IL-10 after consuming the palm-based fats compared to the stearic-rich blend. Both interventions successfully shifted participants’ fatty acid intake as intended.
Limitations
Each intervention lasted six weeks, which prevents assessment of long-term effects. The sample size of 47 participants may have been too small to detect some differences. Participants were healthy adults aged 35 to 65, which limits applicability to other populations or those with existing health conditions. Participants’ other dietary intake was not controlled, and differences in dietary assessment methods between study centers created some variability. Liver fat was measured only at one center in a subgroup. Post-meal testing and flow-mediated dilation were performed in a 24-person subset.
Funding and Disclosures
This research was funded by a research grant from the Malaysian Palm Oil Board. The funders were not involved in the study design, data collection, analysis, interpretation, writing, or publication decisions. Several authors reported relationships with various nutrition and food companies, though most were unrelated to the current study.
Publication Information
Hall, W.L., Wood, E., Joris, P.J., Smith, H.A., Creedon, A., Maher, T., Bruce, J.H., Mensink, R.P., and Berry, S.E. (2025). “The effects of consumption of interesterified fats rich in palmitic acid compared with stearic acid on intermediary markers of cardiometabolic disease risk: a randomized controlled trial in healthy adults,” published September 18, 2025 in The American Journal of Clinical Nutrition. doi:10.1016/j.ajcnut.2025.09.025







